Do EU5 Countries With Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.071
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV